Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095943 Target Snapshot

Histone deacetylase · PROTEIN FAMILY · Rattus norvegicus

138Compounds
25Assays
1Approved Drugs
109.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q6P6W3. Use UniProt Q6P6W3 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6P6W3 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone deacetylase as ChEMBL target CHEMBL2095943, mapped to UniProt Q6P6W3. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone deacetylase
PROTEIN FAMILY · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2095943
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q6P6W3
Histone deacetylase 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone deacetylase is the right protein anchor across sources, using UniProt Q6P6W3 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone deacetylase 3
UniProt AccessionQ6P6W3
Component TypeProtein
Sequence Length428 aa

Histone deacetylase 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone deacetylase, mapped to UniProt Q6P6W3. ChEMBL maps the protein component as Histone deacetylase 3. Sequence length is 428 aa.

Mapped IDQ6P6W3
Review nameHistone deacetylase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC50109.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3319223 8.47 IC50 3.4 Preclinical
CHEMBL3319215 8.44 IC50 3.6 Preclinical
CHEMBL1790587 8.2 IC50 6.29 Preclinical
CHEMBL99 7.92 IC50 12.0 Preclinical
CHEMBL3763388 7.75 IC50 18.0 Preclinical
CHEMBL3764525 7.68 IC50 21.0 Preclinical
CHEMBL360194 7.67 IC50 21.2 Preclinical
CHEMBL435643 7.42 IC50 38.0 Preclinical
CHEMBL203207 7.4 IC50 40.0 Preclinical
CHEMBL140000 7.34 IC50 46.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
7
5.5
35
6.0
31
6.5
8
7.0
12
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VORINOSTAT
CHEMBL98
Approved 2006
Assay Landscape

Assay Landscape

25
Total Assays
75
Tested Compounds
1
Assay Types
Binding — 25 assays, 75 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 18 31 6.8
cell-based format 4 2 8.5
tissue-based format 2 38 6.5
protein format 1 4 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine